Bio-Rad Laboratories (BIO) Shares Climb on Strong Q2 Earnings
Following the release of its second-quarter results report, which surpassed sales projections, Bio-Rad Laboratories, Inc. (NYSE: BIO) saw a significant increase in share price last Friday. BIO’s shares closed at $284.60, up 17.63% for the day. Through careful cost control and rigorous execution, the firm saw strong increase in both revenue and operating profit during […]